LLY - Eli Lilly and Company

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue22,871,30021,222,10019,958,70019,615,600
Cost of Revenue6,070,2005,654,9005,037,2004,932,500
Gross Profit16,801,10015,567,20014,921,50014,683,100
Operating Expenses
Research Development5,281,8005,243,9004,796,4004,733,600
Selling General and Administrative6,588,1006,452,0006,533,0006,620,800
Non Recurring----
Others----
Total Operating Expenses17,940,10017,350,80016,366,60016,286,900
Operating Income or Loss4,931,2003,871,3003,592,1003,328,700
Income from Continuing Operations
Total Other Income/Expenses Net-2,733,800-497,300-802,100-328,400
Earnings Before Interest and Taxes4,931,2003,871,3003,592,1003,328,700
Interest Expense-225,000-185,200-161,200-148,800
Income Before Tax2,197,4003,374,0002,790,0003,000,300
Income Tax Expense2,401,500636,400381,600609,800
Minority Interest75,70072,80019,00014,900
Net Income From Continuing Ops-204,1002,737,6002,408,4002,390,500
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-204,1002,737,6002,408,4002,390,500
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-204,1002,737,6002,408,4002,390,500